Serve as a field-based scientific expert on CTCL and lacutamab, building trusted relationships with HCPs.
Exchange balanced medical information and generate actionable insights to inform US Medical Affairs strategy.
Collaborate with academic, community, and multidisciplinary care teams while ensuring compliance.
Sobi develops and delivers innovative therapies for people with rare diseases. With over 1,900 employees in more than 30 countries, we foster a collaborative, patient-focused culture.
Advance the medical strategy within the assigned territory through fair-balanced, evidence-based scientific exchange and credible partnership with the healthcare community.
Deliver high-quality scientific and clinical presentations on disease states and Iovance products to internal and external audiences, tailoring content to audience needs.
Build and sustain relationships with external experts, collect field medical insights, and support clinical trial site identification and execution.
Iovance Biotherapeutics is a global leader in developing tumor infiltrating lymphocyte (TIL) cell therapies for solid tumors. It is an end-to-end cell therapy company with centralized U.S.-based manufacturing, serving thousands of cancer patients worldwide each year.
Provide field-based scientific expertise in GU Oncology, specifically non-muscle invasive bladder cancer.
Build and maintain scientific relationships with healthcare professionals and external experts.
Support Medical Affairs initiatives including advisory boards, congresses, and scientific exchange.
We are a global commercialization services company for the life sciences industry, helping bring innovative therapies to market. Our team of over 6,000 employees serves more than 650 clients, and we are proud to be a Great Place to Work.
Lead and evolve the national MSL team, defining operational frameworks and best practices.
Translate medical strategy into clear field initiatives and measurable goals.
Oversee compliant MSL engagements with KOLs/HCPs and direct insights collection.
Orca Bio is a commercial-stage biotechnology company developing next-generation cell therapies to improve survival rates and reduce risks for blood cancer patients. The company maintains a start-up culture of camaraderie and leadership by example, driven by passion, courage, and integrity.
Serve as the primary field-based scientific partner to investigators and key stakeholders.
Deliver high-quality scientific exchange on disease state, clinical data, and the ulixacaltimide profile.
Gather and translate field insights to inform medical and cross-functional strategy.
Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. The company values trust, ownership, curiosity, and results, and fosters a collaborative, high-engagement culture.
Develop and maintain peer-to-peer relationships with key opinion leaders and healthcare providers in metabolic and oncology therapeutic areas.
Provide scientific support through virtual or on-site presentations, advisory boards, and medical congress staffing.
Critically evaluate emerging scientific literature to inform internal strategy and external engagement.
Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for severe metabolic and endocrine disorders. The company is mission-driven to bring hope to patients and families affected by rare diseases through scientific innovation and collaboration.
Develop and maintain scientific relationships with healthcare providers and decision makers in the rare disease space.
Gather and disseminate clinical insights on unmet medical needs and treatment paradigms to guide internal strategy.
Support clinical trials and educational activities while ensuring compliance with regulatory and ethical guidelines.
Shionogi is a pharmaceutical company dedicated to developing innovative treatments for patients. It is an emerging US and global organization that values collaboration and a patient-centric approach.
Serve as a field-based scientific resource and trusted exchange partner for key opinion leaders, healthcare professionals, and researchers in oncology.
Conduct all interactions in a factual, objective, non-promotional manner, ensuring compliance with company policies and regulatory requirements.
Demonstrate comprehensive expertise in genomic technologies, precision oncology, and emerging evidence to advance precision medicine research.
Illumina is a global leader in DNA and multi-omic sequencing, manufacturing research use only and in vitro diagnostic products. The company employs thousands worldwide and fosters an inclusive culture of openness, collaboration, and belonging, empowering employees to contribute to health equity.
Execute 12-18 MD-level engagements per quarter across defined geography, with at least 50% in top strategic community accounts.
Serve as primary MD triage for escalated area medical inquiries, ensuring 90% acknowledgment within 48 hours and 100% closed-loop documentation.
Host or present at least 12 regional educational programs per quarter and lead at least one educational initiative per cycle.
Natera is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. The team is made up of highly dedicated professionals from world-class institutions, who care deeply about the work and each other.
Lead strategic medical communication recommendations and scientific content development for assigned accounts.
Oversee creation of manuscripts, posters, abstracts, and other publication deliverables across therapeutic areas.
Supervise Associate Scientific Directors and collaborate with in-house or freelance staff on research, writing, and data-checking tasks.
Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies through medical communications. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live, fostering a flexible, talent-focused culture.
Lead, coach, and develop Field Medical teams to deliver high-quality, compliant scientific engagement in oncology.
Translate medical and therapeutic area strategy into regional field priorities and execution plans.
Partner with Medical Affairs leadership and cross-functional teams to align regional field activity with medical objectives.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. It is a global biopharmaceutical company focused on immunology, oncology, neuroscience, and aesthetics, with a culture of integrity, innovation, and community.
Develop business plans, market analysis, and strategy to achieve or exceed forecasted sales goals in the oncology community.
Build and maintain relationships with key stakeholders, KOLs, and oncology practices to position on-label benefits and resolve access issues.
Collaborate cross-functionally with Market Access, Clinical Education, and Medical Affairs to facilitate customer and patient access to therapies.
Karyopharm Therapeutics is a biopharmaceutical company pioneering nuclear export inhibition to develop differentiated therapies for cancer patients. They are building on an established commercial foundation in multiple myeloma while fostering a collaborative, fast-moving environment where individual contributions are visible and valued.